Anti CD161 Antibody IMT-009 Is a Novel Immunotherapeutic Agent That Effectively Blocks the Inhibitory CLEC2D/CD161 Axis in CLEC2D+B Cell Hematological Malignancies Reinvigorating T and NK Cell Function Leading to Anti-Tumor Benefit

Matthew Bernstein,Elizabeth Scanlon, Alexandria Fusco, Frano Irvine, Flavian D. Brown, Jeffrey D. Colbert,Matthew A. Huggins, Michael Ross,Ming Tang,Shruti Malu

BLOOD(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要